Radioiodine-induced hypothyroidism in Graves' disease: factors associated with the increasing incidence
A retrospective analysis was done of the records of 454 patients who received their first I-131 treatment for Graves' disease during six periods covering 1951 to 1978. In the earliest group, 3% of patients were hypothyroid 3 mo after I-131 use, and 40% were hypothyroid at 1 yr. In the most recent group, 36% of patients were hypothyroid at 3 mo and 91% were myxedematous at 1 yr. Although no obvious trends were noted, whether in the number of patients pretreated with thionamide drugs, in the mean 24-hr I-131 uptake, or in the calculated dose of I-131 (..mu..Ci/estimated gram of thyroid tissue) during the years of the study, the initial mean dose of I-131 administered increased from 8.1 mCi in the earliest group to 13.8 mCi in the latest group. Concurrently, estimates of gland size increased from a mean of 26 g in the first group to 43 g in the last. If, in patients with Graves' disease, the thyroid gland size did not truly increase during the years of the study, the increasing occurrence of early hypothyroidism seen after I-131 use may reflect the conscious or unconscious decision to use larger doses of I-131 calculated on the basis of inflated estimates of thyroid gland weight.
- Research Organization:
- Mayo Clinic, Rochester, MN
- OSTI ID:
- 6374593
- Journal Information:
- J. Nucl. Med.; (United States), Vol. 23:11
- Country of Publication:
- United States
- Language:
- English
Similar Records
Graves' disease radioiodine-therapy: Choosing target absorbed doses for therapy planning
Graves' disease radioiodine-therapy: Choosing target absorbed doses for therapy planning
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
HYPOTHYROIDISM
RADIOINDUCTION
RADIOTHERAPY
SIDE EFFECTS
THYROID
RADIATION DOSES
ENDOCRINE DISEASES
IODINE 131
PATIENTS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
DAYS LIVING RADIOISOTOPES
DISEASES
DOSES
ENDOCRINE GLANDS
GLANDS
INTERMEDIATE MASS NUCLEI
IODINE ISOTOPES
ISOTOPES
MEDICINE
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANS
RADIOISOTOPES
RADIOLOGY
THERAPY
560161* - Radionuclide Effects
Kinetics
& Toxicology- Man
550604 - Medicine- Unsealed Radionuclides in Therapy- (1980-)